CRISTINA GAMEZ-CENZANO

Nuclear Medicine Specialist/Head (from 2024)

Hospital Universitari Vall d'Hebron

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Cristina Gamez-Cenzano is a Nuclear Medicine Specialist and the Head of the Nuclear Medicine department at Hospital Universitari Vall d'Hebron, ICS-IDI, Spain. Her research focuses on the safety and efficacy of nuclear medicine in oncology, including recent work on the use of [177Lu]Lu-DOTA-TATE in neuroendocrine tumors and the role of PET/CT imaging in cancer therapy response prediction. She is also involved in developing diagnostic methodologies for various oncological conditions.

Articles (6)

Year:

2025

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Daria Handkiewicz-Junak

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Mark N Gaze

University College London Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

CRISTINA GAMEZ-CENZANO

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study

Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma

Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival.

Diagnostic methodology in labelled leukocyte scan for prosthetic / non-prosthetic osteoarticular infection: Visual or semi-quantitative analysis? One- or two-day protocol?

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Amyloid Arthropathy Associated to Multiple Myeloma

Fluorodeoxyglucose positron emission tomography/computed tomography in amyloid arthropathy associated to multiple myeloma

Collaborators (2)

Daria Handkiewicz-Junak

Mark N Gaze

Make your next move.